Editorial: Present and future of biological fluid biomarkers in dementia
Open Access
- 20 November 2023
- journal article
- editorial
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 15, 1331799
Abstract
Editorial: Present and future of biological fluid biomarkers in dementiaKeywords
This publication has 9 references indexed in Scilit:
- Brain-derived tau: a novel blood-based biomarker for Alzheimer’s disease-type neurodegenerationBrain, 2022
- Fluid biomarkers in Alzheimer's disease2022
- Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer’s diseaseActa Neuropathologica, 2022
- Blood-based biomarkers for Alzheimer's disease: towards clinical implementationThe Lancet Neurology, 2022
- Biological Significance of the Protein Changes Occurring in the Cerebrospinal Fluid of Alzheimer’s Disease Patients: Getting Clues from Proteomic StudiesDiagnostics, 2021
- Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future PerspectivesBrain Sciences, 2021
- Urinary Biomarkers for Neurodegenerative DiseasesExperimental Neurobiology, 2020
- A comprehensive systematic review of CSF proteins and peptides that define Alzheimer’s diseaseClinical Proteomics, 2020
- Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s diseaseActa Neuropathologica, 2019